IDYA•benzinga•
Guggenheim Maintains Buy on IDEAYA Biosciences, Raises Price Target to $32
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga